Delivery Order SPE2DB22D2007-SPE2DB24FJ5XB
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D6036|SPE2DB24FC8PB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $1,361.37 firm-fixed-price delivery order is for the supply of QSYMIA 7.5 MG-46 MG CAPSULE 30S, a pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Qsymia 3.75 mg-23 mg capsules, a prescription medication, with a ceiling value of $1,613.04 and a completion date of August 7, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. Amerisourcebergen Drug...
This federal contract award, valued at $1,525.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it covers the supply of the pharmaceutical product QSYMIA 15 MG-92 MG CAPSULE 30S.
The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. It is not designated as a...
This federal contract award, valued at $2,867.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of QSYMIA 7.5 MG-46 MG capsules, a prescription medication, to support federal healthcare programs.
Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other agencies, such as the Department of Justice Federal Bureau of...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,125.52 Firm Fixed Price delivery order contract is for the supply of QSYMIA 7.5 MG-46 MG capsules. The contract has an ultimate completion date of October 23, 2024 and was not set aside for any specific business types.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,078.28 firm fixed-price delivery order is for the supply of QSYMIA 11.25 MG-69 MG capsules. The contract has an ultimate completion date of November 19, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $2,026.99 firm fixed price delivery order is for the supply of QSYMIA 3.75 MG-23 MG capsules, a prescription medication.
The award is a task order under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the sole prime contractor. This IDC...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB24FXA05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,180.33 firm-fixed-price delivery order is for the supply of QSYMIA 3.75 MG-23 MG capsules, a pharmaceutical product. The contract has an ultimate completion date of September 19, 2024. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded multiple indefinite delivery...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Qsymia 15mg-92mg in 30-count packages. The contract, valued at $2,990.04, is a delivery order with a firm fixed price and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...